Upgrade to SI Premium - Free Trial

Esperion Therapeutics (ESPR)

3.18 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/4/26)

Latest Headlines

Form 15-12G Esperion Therapeutics, July 23, 2026 8:42 AM - SEC Filing Form EFFECT Esperion Therapeutics, July 16, 2026 6:05 AM - SEC Filing Form EFFECT Esperion Therapeutics, July 16, 2026 6:05 AM - SEC Filing Form EFFECT Esperion Therapeutics, July 16, 2026 6:05 AM - SEC Filing Form EFFECT Esperion Therapeutics, July 16, 2026 6:05 AM - SEC Filing Form EFFECT Esperion Therapeutics, July 16, 2026 6:05 AM - SEC Filing Form EFFECT Esperion Therapeutics, July 16, 2026 6:05 AM - SEC Filing Form SCHEDULE 13G/A Esperion Therapeutics, Filed by: WASATCH ADVISORS LP July 14, 2026 5:09 PM - SEC Filing Form 4 Esperion Therapeutics, For: Jul 13 Filed by: Hoffman Robert E. July 13, 2026 4:06 PM - SEC Filing Form 4 Esperion Therapeutics, For: Jul 13 Filed by: CARROLL J MARTIN July 13, 2026 4:06 PM - SEC Filing Form 4 Esperion Therapeutics, For: Jul 13 Filed by: Shepard Jay July 13, 2026 4:06 PM - SEC Filing Form 4 Esperion Therapeutics, For: Jul 13 Filed by: Fischer Seth H. Z. July 13, 2026 4:05 PM - SEC Filing Form 4 Esperion Therapeutics, For: Jul 13 Filed by: THOMPSON JOHN CRAIG July 13, 2026 4:05 PM - SEC Filing Form 4 Esperion Therapeutics, For: Jul 13 Filed by: Harlow John B. Jr. July 13, 2026 4:04 PM - SEC Filing Form 4 Esperion Therapeutics, For: Jul 13 Filed by: Looker Benjamin July 13, 2026 4:04 PM - SEC Filing Form 4 Esperion Therapeutics, For: Jul 13 Filed by: Halladay Benjamin July 13, 2026 4:04 PM - SEC Filing Form 4 Esperion Therapeutics, For: Jul 13 Filed by: Koenig Sheldon L. July 13, 2026 4:03 PM - SEC Filing Form POSASR Esperion Therapeutics, July 13, 2026 12:06 PM - SEC Filing Form POS AM Esperion Therapeutics, July 13, 2026 12:05 PM - SEC Filing Form POS AM Esperion Therapeutics, July 13, 2026 12:04 PM - SEC Filing Form POS462B Esperion Therapeutics, July 13, 2026 12:03 PM - SEC Filing Form POS AM Esperion Therapeutics, July 13, 2026 12:01 PM - SEC Filing Form POS AM Esperion Therapeutics, July 13, 2026 12:00 PM - SEC Filing Form POS AM Esperion Therapeutics, July 13, 2026 11:58 AM - SEC Filing Form POS AM Esperion Therapeutics, July 13, 2026 11:57 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:55 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:54 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:53 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:52 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:51 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:50 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:49 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:48 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:47 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:44 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:43 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:42 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:41 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:40 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:39 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:38 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:37 AM - SEC Filing Form S-8 POS Esperion Therapeutics, July 13, 2026 11:36 AM - SEC Filing Form 25-NSE Esperion Therapeutics, Filed by: Nasdaq Stock Market LLC July 13, 2026 9:19 AM - SEC Filing Form 8-K Esperion Therapeutics, For: Jul 13 July 13, 2026 9:11 AM - SEC Filing Form 8-K Esperion Therapeutics, For: Jul 08 July 8, 2026 8:33 AM - SEC Filing Form 4 Esperion Therapeutics, For: Jun 17 Filed by: Looker Benjamin June 18, 2026 4:07 PM - SEC Filing Form 4 Esperion Therapeutics, For: Jun 17 Filed by: Koenig Sheldon L. June 18, 2026 4:06 PM - SEC Filing Form 4 Esperion Therapeutics, For: Jun 17 Filed by: Halladay Benjamin June 18, 2026 4:06 PM - SEC Filing Form 8-K/A Esperion Therapeutics, For: Apr 02 June 18, 2026 4:05 PM - SEC Filing Form 144 Esperion Therapeutics, Filed by: Koenig Sheldon L. June 17, 2026 3:35 PM - SEC Filing Form 144 Esperion Therapeutics, Filed by: Halladay Benjamin June 17, 2026 3:23 PM - SEC Filing Form 144 Esperion Therapeutics, Filed by: Looker Benjamin June 17, 2026 3:12 PM - SEC Filing Form DEFA14A Esperion Therapeutics, June 16, 2026 4:02 PM - SEC Filing Form 8-K Esperion Therapeutics, For: Jun 15 June 16, 2026 4:01 PM - SEC Filing Form 8-K Esperion Therapeutics, For: Jun 02 June 9, 2026 4:01 PM - SEC Filing Form SCHEDULE 13G Esperion Therapeutics, Filed by: GLAZER CAPITAL, LLC June 8, 2026 5:10 PM - SEC Filing Form DEFM14A Esperion Therapeutics, June 8, 2026 6:03 AM - SEC Filing Form 4 Esperion Therapeutics, For: May 28 Filed by: THOMPSON JOHN CRAIG June 1, 2026 4:24 PM - SEC Filing Form 4 Esperion Therapeutics, For: May 28 Filed by: Shepard Jay June 1, 2026 4:24 PM - SEC Filing Form 4 Esperion Therapeutics, For: May 28 Filed by: Hoffman Robert E. June 1, 2026 4:23 PM - SEC Filing Form 4 Esperion Therapeutics, For: May 28 Filed by: Fischer Seth H. Z. June 1, 2026 4:23 PM - SEC Filing Form 4 Esperion Therapeutics, For: May 28 Filed by: CARROLL J MARTIN June 1, 2026 4:22 PM - SEC Filing Form 8-K Esperion Therapeutics, For: May 28 June 1, 2026 4:22 PM - SEC Filing Form PREM14A Esperion Therapeutics, For: May 29 May 29, 2026 5:17 PM - SEC Filing Esperion presents pediatric bempedoic acid data at European congress May 26, 2026 8:00 AM - StreetInsider Esperion Presents New Data from CLEAR Outcomes and the CLEAR PATH Phase 2 Pediatric Study at the European Atherosclerosis Society Congress 2026 May 26, 2026 8:00 AM - StreetInsider Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May 14, 2026 4:30 PM - StreetInsider Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Society (EAS) Congress 2026 May 13, 2026 8:00 AM - Globe NewsWire Form 10-Q Esperion Therapeutics, For: Mar 31 May 8, 2026 4:12 PM - SEC Filing Form DEFA14A Esperion Therapeutics, May 4, 2026 4:05 PM - SEC Filing Needham Downgrades Esperion Therapeutics (ESPR) to Hold May 4, 2026 3:11 PM - StreetInsider Form DEFA14A Esperion Therapeutics, May 1, 2026 4:00 PM - SEC Filing Jefferies Downgrades Esperion Therapeutics (ESPR) to Hold, PT to $3.28 May 1, 2026 3:15 PM - StreetInsider Piper Sandler Downgrades Esperion Therapeutics (ESPR) to Neutral May 1, 2026 1:56 PM - StreetInsider Form 8-K Esperion Therapeutics, For: May 01 May 1, 2026 11:50 AM - SEC Filing Form DEFA14A Esperion Therapeutics, May 1, 2026 11:50 AM - SEC Filing H.C. Wainwright Downgrades Esperion Therapeutics (ESPR) to Neutral May 1, 2026 9:36 AM - StreetInsider Cantor Fitzgerald Downgrades Esperion Therapeutics (ESPR) to Neutral May 1, 2026 8:38 AM - StreetInsider ARCHIMED to acquire Esperion for $3.16 per share plus milestone payments May 1, 2026 7:01 AM - StreetInsider Esperion to be Acquired by ARCHIMED May 1, 2026 7:00 AM - Globe NewsWire Full Article List